Comment: Expense of Amphotericin B Product

Annals of Pharmacotherapy

Volumn 30, Issue 11, 1996, Pages 1342-

  Andersen, Judith m ^a  

^a Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG STABILITY; LETTER; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; FAT EMULSIONS, INTRAVENOUS; HUMANS; SOLUTIONS;

EID: 0029911371     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809603001127     Document Type: Letter

References (2)

1. Cleary JD. Amphotericin B formulated in a lipid emulsion. Ann Pharmacother 1996;30:409-12.
2. Pascual B, Ayestaran A, Montoro JB, Oliveras J, Estibalez A, Julia A, et al. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia. Ann Pharmacother 1995;29:1197-201.